<DOC>
	<DOCNO>NCT02657694</DOCNO>
	<brief_summary>REDEMPTION ( Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods ) observe collate treatment course , safety profile , outcomes patient around world choose self import generic version Direct Acting Antivirals Sofosbuvir , Ledipasvir Daclatasvir country like China , India Bangladesh .</brief_summary>
	<brief_title>Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods</brief_title>
	<detailed_description>The high price Hepatitis C Virus ( HCV ) Direct Acting Antiviral ( DAA ) medication many country lead patient seek less expensive generic alternative . The efficacy safety generic medication formally demonstrate clinical practice . The primary goal REDEMPTION collate clinical result generic medication . The secondary goal answer efficacy question currently insufficient trial data available - example Sofosbuvir+Daclatasvir appear inexpensive pan genotypic solution treat HCV globally support total n less 1000 , common genotype , HCV Genotype 2 , n 52 make wide margin error high degree uncertainty .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Ledipasvir</mesh_term>
	<criteria>Quantitative HCV RNA &gt; 100 Contraindications DAA medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>